Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer.
Quick Facts
What This Study Found
CPPs can improve drug delivery and targeting in cancer treatment, showing significant potential in clinical trials.
Key Numbers
How They Did This
The study is a review based on systematic searches in multiple scientific databases.
Why This Research Matters
CPPs could revolutionize cancer treatment by enhancing drug delivery and reducing side effects, making therapies more effective.
What This Study Doesn't Tell Us
As a review, it does not present original experimental data and relies on existing studies.
Trust & Context
- Original Title:
- Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer.
- Published In:
- Cancers, 14(22) (2022)
- Authors:
- Bottens, Ryan A, Yamada, Tohru
- Database ID:
- RPEP-06014
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06014APA
Bottens, Ryan A; Yamada, Tohru. (2022). Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer.. Cancers, 14(22). https://doi.org/10.3390/cancers14225546
MLA
Bottens, Ryan A, et al. "Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer.." Cancers, 2022. https://doi.org/10.3390/cancers14225546
RethinkPeptides
RethinkPeptides Research Database. "Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnost..." RPEP-06014. Retrieved from https://rethinkpeptides.com/research/bottens-2022-cellpenetrating-peptides-cpps-as
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.